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With advances in surgical procedures and perioperative management, hepato-biliary-pancreatic surgery, including
hepatectomy and pancreaticoduodenectomy, has been employed for recurrent colon cancer. However, no report
has described a case of major hepatectomy with the combined resection of hepaticojejunostomy following
pancreaticoduodenectomy for locoregionally recurrent colon cancer. Here, such a case is reported. The patient, a
37-year-old woman, had undergone pancreaticoduodenectomy for lymph node recurrence along the extrahepatic
bile duct from cecal cancer. Thirteen months later, a biliary stricture was found at the hepaticojejunostomy site and
right hepatectomy was performed. The resected specimen showed a papillary tumor at the hepaticojejunostomy.
Based on its histological features, the pathogenesis of this tumor was considered to be intramural recurrence via lymphatic
vessels. Although she underwent resection of a lymph node recurrence at her mesentery 12 months later, she has remained
well thereafter, without any sign of further recurrence during 5 years of follow-up after hepatectomy.
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The management of locoregionally recurrent colon cancer
poses a surgical challenge since these lesions often extend
into surrounding structures and organs. Surgery is the sole
curative modality that can result in long-term survival after
complete resection alone [1]. Usually, the abdominal wall, ur-
eter, kidney, stomach, uterus, or distal part of the pancreas is
resected in attempts to achieve complete resection. In con-
trast, pancreaticoduodenectomy (PD) and major hepatec-
tomy with combined resection of the extrahepatic bile duct
are rarely indicated. Herein, we report a case in which a
tumor at the site of hepaticojejunostomy was successfully
resected with a right hemihepatectomy 2 years after PD for
lymph node recurrence of cecal cancer.Case presentation
The patient was a 37-year-old woman who had undergone
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in any medium, provided the original work is pHistological examination revealed a well-differentiated
adenocarcinoma with mucinous carcinoma, which had in-
vaded the serosal layer without regional lymph node metasta-
sis. A slight lymphatic and vascular invasion was evident.
Finally, her tumor was diagnosed as T4aN0M0, stage II B ac-
cording to UICC classification [2] (Figure 1). Adjuvant
chemotherapy with tegafur-uracil and leucovorin (UFT/
UZEL) was administered. However, 6 months after her initial
operation, a tumor along the extrahepatic bile duct (diam-
eter: 2 cm) was detected by computed tomography (CT).
Although hyperbilirubinemia or elevation of biliary enzyme
was not seen in her laboratory study, the tumor was located
extremely close to the dorsal part of the bile duct and pan-
creatic parenchyma. It was considered to be a lymph node
metastasis from cecal cancer. First, she was treated with sys-
temic chemotherapy of oxaliplatin with fluorouracil and foli-
nic acid (FOLFOX4) for nine courses and irinotecan with
fluorouracil and folinic acid (FOLFILI) for six courses.
However, chemotherapy was not effective for her recurrent
tumor. Moreover, she suffered from severe adverse effect of
chemotherapy including grade 3 diarrhea, peripheral neur-
opathy, and grade 2 neutropenia and could not walk bys an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Figure 1 Histological findings of the initial operation.
Histological examination of initial operation revealed a
well-differentiated adenocarcinoma with mucinous carcinoma
(H&E, hematoxylin and eosin stain, low magnification).
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treatment. Since major vessel involvement of the recurrent
tumor was not shown by CT, we considered that complete
resection would be achieved by pancreaticoduodenectomy.
She underwent subtotal stomach-preserving pancreaticoduo-
denectomy. Histologically, the lymph node along the extra-
hepatic bile duct was involved by well-differentiated
adenocarcinoma with mucinous carcinoma, which is similar
to cecal cancer. Tumor invasion to the lymphatic vessels was
also observed (Figure 2A,B,C).
For 13 months after her second operation, the patient
remained well without any adjuvant therapy. However, she
subsequently manifested obstructive jaundice. CT demon-
strated wall thickening with mild enhancement of the bile
duct at the hepatic bifurcation adjacent to the jejunum
and upstream dilatation of the bilateral hepatic ducts
(Figure 3A). Cholangiography via a percutaneous transhe-
patic biliary drainage tube revealed a filling defect at the
hepaticojejunostomy (Figure 3B). Because a biopsy speci-
men taken via percutaneous transhepatic cholangioscopy
did not show malignant cells, she did not receive further
treatment, with the exception of biliary stenting. However,
cholangiography performed 8 months later revealed an
enlarged filling defect extending from hepatic bifurcation
to the confluence of the right anterior and posterior
branch. Moreover, positron-emission tomography revealed
an abnormal uptake at the anastomotic site (Figure 3C).
From these, she was diagnosed as having anastomotic re-
currence. Although we proposed an alternative plan of
neoadjuvant chemotherapy, she strongly refused it for fear
of severe adverse effect which she had experienced after
initial recurrence. Moreover, major vessel involvement of
the anastomotic tumor was not shown by CT. Thus, we
considered that complete resection of the tumor would be
achieved by hepatectomy with bile duct resection. She
underwent a third operation 2 years after her secondoperation. Radical surgery was performed by en bloc resec-
tion of the right hepatic and caudate lobes and the anasto-
motic region of the bile duct and jejunum. The jejunum
around the anastomosis was resected with a 1-cm margin
and closed by suturing transversally (Figure 4A). A
renewed hepaticojejunostomy was created between the left
hepatic duct and the inverted blind end of the jejunum
(Figure 4B). The operation time was 413 min and there
was 690 ml of blood loss. The resected specimen con-
tained a polypoid tumor at the hepaticojejunostomy
(Figure 5A). Microscopic f indings showed well-
differentiated adenocarcinoma with mucinous carcinoma
similar to the primary and secondary cancers. The polyp-
oid tumor grew from the submucosal layer of the bile
duct, in which many dilated lymphatic vessels with tumor
invasion were observed. Intraepithelial spread of tumor
cells was evident in neither the bile duct nor the jejunum
(Figure 5B,C).
The patient was discharged from the hospital 26 days
after the operation without any complications. Although
she underwent a fourth operation for lymph node recur-
rence at her mesentery 12 months later, she has remained
well thereafter, without any sign of further recurrence dur-
ing the 5 years of follow-up after the hepatectomy.
Discussion
Distant sites, such as the liver or lung, account for the major-
ity of initial recurrence of resected colon cancers.
Locoregional recurrence, as the first site of relapse, is much
less common, constituting 10% to 20% of all recurrences
[3,4]. Surgery is the only potentially curative therapy for pa-
tients suffering from locoregionally recurrent colon cancer.
Outcomes following salvage surgery are closely associated
with the completeness of resection. It has been reported that
patients who underwent curative resection had a 5-year sur-
vival rate of 58% and a median survival time of 66 months,
while no patients in incomplete resection cohorts survived
5 years [5]. Therefore, surgeons should perform surgery if
complete resection will be promising. However, needless to
say, the indication for surgical treatment should be carefully
determined with consideration of risks and benefits of sur-
gery. In addition, neoadjuvant multidisciplinary approach in-
cluding chemotherapy or molecular targeted therapy has a
possibility of contributing to achieve complete resection and
long-term survival. In our case, since the surgical stress of
pancreaticoduodenectomy or hepatectomy with bile duct re-
section is extremely large and incomplete resection might
shorten the duration of survival, we carefully discussed the
treatment strategy before the second and third operation.
However, unfortunately, the adverse effect of chemotherapy
was severe, and it was not effective for her recurrent tumor.
With advances in hepato-biliary-pancreatic surgery, hepa-
topancreaticoduodenectomy (HPD) has been employed for
advanced biliary tract cancer with relatively low morbidity
Figure 2 Histological findings of the second operation. Histologically, the lymph node along the extrahepatic bile duct was involved by well-
differentiated adenocarcinoma with mucinous carcinoma, which is similar to cecal cancer ((A) H&E, original magnification; (B) H&E, low magnification).
Immunostaining with D2-40 monoclonal antibody which is a specific marker for lymphatic vessel elucidated tumor invasion to lymphatic vessels (C).
Figure 3 Preoperative images of the third operation. (A) Computed tomography demonstrated wall thickening with mild enhancement of
the bile duct at the hepatic bifurcation adjacent to the jejunum (arrow) and upstream dilatation of the bilateral hepatic ducts. (B) Catheter
cholangiogram through the percutaneous transhepatic biliary drainage tube revealed a filling defect at the site of hepaticojejunostomy (dotted
arrow). (C) Positron-emission tomography revealed an abnormal uptake at the anastomotic site.
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Figure 4 Schematic presentation of the operative procedures. (A) The jejunum around the anastomosis (*) was resected with a 1-cm margin
(arrow line). (B) The jejunum was closed with suturing transversally (*). A renewed hepaticojejunostomy was created between the left hepatic
duct and the inverted blind end of the jejunum.
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formed for recurrent or metastatic cancer has also been re-
ported [8,9]. Few reports have described cases of major
hepatectomy with combined resection of hepaticojejunost-
omy following PD, although several reports have described
cases of simple hepatectomy following PD without resectionFigure 5 The resected specimen and microscopic findings. (A) The resec
(arrow). (B, C) Microscopic findings showed well-differentiated adenocarcinom
cancers. The polypoid tumor grew from the submucosal layer of the bile duct
invasion were observed. Intraepithelial spread of tumor cells was evident in n
(C) H&E, high magnification).of bilioenteric anastomosis [10,11]. This may be explained by
the technical difficulties and the extremely rarity of perform-
ing two major operations in a single patient at different
times. To the best of our knowledge, the English language lit-
erature includes only seven cases of major hepatectomy with
combined resection of hepaticojejunostomy following PD,ted specimen contained a polypoid tumor at the hepaticojejunostomy
a with mucinous carcinoma similar to the primary and secondary
(dotted arrow), in which many dilated lymphatic vessels with tumor
either the bile duct nor the jejunum ((B) H&E, original magnification;
Table 1 Reported seven cases of patients undergoing major hepatectomy with combined resection of
hepaticojejunostomy following PD
No Authors Year Age Sex Primary disease Time (M) Type of hepatectomy Pathogenesis of secondary lesion Outcome
1 Seki 1998 75 M Bile duct Ca 50 Right hepatectomy Second primary cancer 6 M, D
2 Seki 1998 68 M Bile duct Ca 153 Right hepatectomy Second primary cancer 6 M, D
3 Seki 1998 69 F Bile duct Ca 70 Right hepatectomy Recurrence 17 M, A
4 Hibi 2006 65 M Bile duct Ca 36 Right hepatectomy Second primary cancer 8 M, A
5 Sasaki 2006 45 M Bile duct Ca 108 Right hepatectomy Recurrence 30 M, D
6 Okamura 2011 60 F Bile duct Ca 48 Right hepatectomy Recurrence 40 M, A
7 Current 2014 37 F Cecal Ca 13 Right hepatectomy Recurrence 64 M, A
PD, pancreaticoduodenectomy; No, number of patients; Time (M), time between two operations (months); Outcome, prognosis after the second surgery; M,
month; D, dead; A, alive; Ca, cancer.
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male in four cases and female in three cases. The average age
of the patient was 59.9 years. In six cases, the primary disease
was bile duct cancer; the primary disease was recurrent colon
cancer in our case alone. The average time between the two
operations was 68.3 months. In all cases, right hepatectomy
was selected. Secondary surgery was performed for recur-
rence of the primary lesion in four cases (including ours),
while it was performed for a second primary cancer in the
remaining three cases. There were two cases in which the
patient survived longer than 3 years.
In the current case, the anastomotic tumor may have
been the result of intramural recurrence via the lymph-
atic vessels because tumor invasion to the lymphatic ves-
sels was observed in both the metastasized lymph node
that was resected with PD and the anastomotic tumor
(microscopically). We considered two other possible expla-
nations of the pathogenesis. The first relates to the develop-
ment of the second primary cholangiocarcinoma after
bilioenteric anastomosis. Repeated chronic inflammation due
to regurgitation from anastomosis evokes epithelial damage,
resulting in carcinogenesis, and is the only independent pre-
dictor of the development of cholangiocarcinoma [16].
However, the pathological features of the anastomotic tumor
were inconsistent with this etiology because findings that
suggest chronic inflammatory reaction were absent and
intraepithelial tumor cells were not seen in the bile duct mu-
cosa, except for the anastomotic lesion. The second possible
explanation is intraluminal implantation. This is a well-
known manner of recurrence in colorectal cancer. Gertsch
et al. [17] showed that, after completing anastomosis with a
circular stapler, malignant cells were collected in the centri-
fuged saline in which the stapler had been washed. This type
of recurrence has also been reported in bile duct carcinoma.
Tanaka et al. [18] reported a case of anastomotic recurrence
at hepaticojejunostomy in a 10-year survivor of bile duct car-
cinoma and demonstrated that possible mechanisms of re-
currence were a suture implantation or the deposition of
intraluminal tumor cells at the anastomotic site. In our case,
this is less likely to be the etiology of the anastomotic tumorbecause tumor cells must be absent from the bile duct when
performing hepaticojejunostomy in the previous operation.
Nonetheless, the possibility of implantation via the surgical
forceps that were used during dissection of the metastatic
lymph nodes could not be completely denied.
In the present case, a renewed hepaticojejunostomy was
created between the left hepatic duct and the inverted
blind end of the jejunum. However, in all previously re-
ported cases, bilioenteric continuity was reestablished
using the lower jejunum. At the previous surgery, the
lifted jejunum and its mesentery (for bilio- and pancreato-
enteric reconstruction) were usually fixed to the mesen-
tery of the transverse colon in order to prevent internal
hernia. Therefore, the lower jejunum was unlikely to have
enough length to complete the renewed hepaticojejunost-
omy safely. Our method appears to be advantageous when
the blind end of the jejunum is sufficiently long.
Conclusions
We have reported a case of a tumor at hepaticojejunost-
omy that was successfully resected with right hemihepa-
tectomy 2 years after pancreaticoduodenectomy for lymph
node recurrence of cecal cancer. The pathogenesis of the
anastomotic tumor was considered to be intramural recur-
rence via lymphatic vessels. Aggressive surgery should be
performed to achieve long-term survival in cases of locor-
egionally recurrent colon cancer, even if the surgery is
technically demanding.
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